Sharper scans for prostate cancer? new MRI dye aims for clearer picture

NCT ID NCT06226129

Summary

This study is testing a new dye called Gadopiclenol used during prostate MRI scans. The goal is to see if this dye makes aggressive prostate cancer show up more clearly, helping doctors better identify which areas need a biopsy. Researchers will compare the MRI results with biopsy findings from 150 men who are already scheduled for these procedures.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia University Medical Center

    RECRUITING

    New York, New York, 10032, United States

    Contact

Conditions

Explore the condition pages connected to this study.